X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Tags:
Thumbnail
Which of these household names is the better buy? [Read More]
Galapagos undefinedundefined rose nearly 3% in early Amsterdam trade as Phase 3 studies of drug it's making with Gilead Sciences undefined showed "sustained... [Read More]
Galapagos GLPG, +2.86% ... [Read More]
Thumbnail
Gilead Sciences Inc.'s potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug... [Read More]
SVB Leerink upgrades its stock... [Read More]
Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug... [Read More]
SVB Leerink upgraded Gilead Sciences to outperform, citing the sales potential of the coronavirus drug remdesivir. [Read More]
A body recovered from the Kokosing River Sunday has been identified as a missing Mount Gilead man. [Read More]
A body recovered from the Kokosing River Sunday has been identified as a missing Mount Gilead man. Mount Vernon Police Chief Robert Morgan said Wednesday... [Read More]
SVB Leerink thinks sales will rise into the billions of dollars. So analyst Geoffrey Porges raised the stock to Outperform in a Wednesday morning note,... [Read More]
Shares of Gilead Sciences Inc. GILD, -2.52% ... [Read More]
Shares of Gilead Sciences Inc. undefined gained 1.1% in premarket trading on Wednesday after SVB Leerink upgraded the drugmaker to outperform from market... [Read More]
Earl R. Todd, 86, of Mount Gilead, died Monday at Morrow Manor Nursing Center, Chesterville.Snyder Funeral Homes, Mount Gilead, is handling arrangements. [Read More]
India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients. [Read More]
Lilly (LLY) begins phase I study on a potential antibody therapy to treat COVID-19. Gilead (GILD) announces mixed results from the second phase III study... [Read More]
The European Society for Blood and Marrow Transplantation (EBMT) announces a new collaboration with Kite, a Gilead Company, to study the long-term outcomes of patients... [Read More]
The results may shift perceptions of the therapy already cleared for use in severe coronavirus cases. [Read More]
Gilead Sciences is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be... [Read More]
Gilead Sciences Inc. is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can... [Read More]
A five-day course of the antiviral drug remdesivir sped recovery in moderately ill patients with pneumonia from Covid-19, drugmaker Gilead Sciences announced in a statement... [Read More]
Loading...
Save As
Preview
Preview